SPONSOR
Johnson & Johnson Enterprise Innovation Inc.
Total Trials
2
Recruiting
2
Phases
Phase 1
Johnson & Johnson Enterprise Innovation Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Neoplasms, Squamous Cell Carcinoma of Head and Neck.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Johnson & Johnson Enterprise Innovation Inc.
How many clinical trials has Johnson & Johnson Enterprise Innovation Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Johnson & Johnson Enterprise Innovation Inc., of which 2 are actively recruiting participants. These trials cover conditions including Neoplasms, Squamous Cell Carcinoma of Head and Neck. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Johnson & Johnson Enterprise Innovation Inc. research focus on?
Johnson & Johnson Enterprise Innovation Inc. clinical trials span Neoplasms, Squamous Cell Carcinoma of Head and Neck. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Johnson & Johnson Enterprise Innovation Inc. clinical trial?
To participate in a Johnson & Johnson Enterprise Innovation Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Johnson & Johnson Enterprise Innovation Inc. trials with current recruitment status updated daily.
Clinical Trials by Johnson & Johnson Enterprise Innovation Inc.
NCT06311578 Phase 1
Recruiting
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
Neoplasms
NCT07219212 Phase 1
Recruiting
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
Squamous Cell Carcinoma of Head and Neck
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology